Security Snapshot

20/20 Biolabs, Inc. - Common Stock, par value $0.01 (AIDX) Institutional Ownership

CUSIP: 90138K101

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$2.80

Type / Class
Equity / Common Stock, par value $0.01
Symbol
AIDX on Nasdaq
Shares outstanding
10,340,714
Price per share
$2.80

Sponsored

Quick Takeaways

  • AIDX - 20/20 Biolabs, Inc. - Common Stock, par value $0.01 is tracked under CUSIP 90138K101.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Quarterly ownership records are not available yet for this CUSIP.
  • This page updates as SEC-backed holdings history becomes available.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Schedule 13D/13G

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 90138K101?
CUSIP 90138K101 identifies AIDX - 20/20 Biolabs, Inc. - Common Stock, par value $0.01 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of 20/20 Biolabs, Inc. - Common Stock, par value $0.01 (AIDX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cohen Jonathan M 17% 1,833,750 Jonathan M Cohen 03 Mar 2026
Full Succeed International Ltd 6.3% 651,465 Full Succeed International Limited 19 Feb 2026
Streeterville Capital LLC 9.9% 543,680 Streeterville Capital LLC 25 Feb 2026

Sponsored